Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital

Summary Background Early coronavirus disease 2019 (COVID-19) diagnosis prior to laboratory testing results is crucial for infection control in hospitals. Models exist predicting COVID-19 diagnosis, but significant concerns exist regarding methodology and generalizability. Aim To generate the first C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:QJM : An International Journal of Medicine 2021-12, Vol.114 (10), p.699-705
Hauptverfasser: Fink, D L, Khan, P Y, Goldman, N, Cai, J, Hone, L, Mooney, C, El-Shakankery, K H, Sismey, G, Whitford, V, Marks, M, Thomas, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 705
container_issue 10
container_start_page 699
container_title QJM : An International Journal of Medicine
container_volume 114
creator Fink, D L
Khan, P Y
Goldman, N
Cai, J
Hone, L
Mooney, C
El-Shakankery, K H
Sismey, G
Whitford, V
Marks, M
Thomas, S
description Summary Background Early coronavirus disease 2019 (COVID-19) diagnosis prior to laboratory testing results is crucial for infection control in hospitals. Models exist predicting COVID-19 diagnosis, but significant concerns exist regarding methodology and generalizability. Aim To generate the first COVID-19 diagnosis risk score for use at the time of hospital admission using the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) checklist. Design A multivariable diagnostic prediction model for COVID-19 using the TRIPOD checklist applied to a large single-centre retrospective observational study of patients with suspected COVID-19. Methods 581 individuals were admitted with suspected COVID-19; the majority had laboratory-confirmed COVID-19 (420/581, 72.2%). Retrospective collection was performed of electronic clinical records and pathology data. Results The final multivariable model demonstrated AUC 0.8535 (95% confidence interval 0.8121–0.8950). The final model used six clinical variables that are routinely available in most low and high-resource settings. Using a cut-off of 2, the derived risk score has a sensitivity of 78.1% and specificity of 86.8%. At COVID-19 prevalence of 10% the model has a negative predictive value (NPV) of 96.5%. Conclusions Our risk score is intended for diagnosis of COVID-19 in individuals admitted to hospital with suspected COVID-19. The score is the first developed for COVID-19 diagnosis using the TRIPOD checklist. It may be effective as a tool to rule out COVID-19 and function at different pandemic phases of variable COVID-19 prevalence. The simple score could be used by any healthcare worker to support hospital infection control prior to laboratory testing results.
doi_str_mv 10.1093/qjmed/hcaa305
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7717412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/qjmed/hcaa305</oup_id><sourcerecordid>2458959379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-ebff6a5b1e3c6732fb2d2d88e1a1ab08f5558a248677e29f7b7d5f0347a14123</originalsourceid><addsrcrecordid>eNqFkctP3DAQxi1UVB7tsdfKx15S_Ijj5FKpWtqChMQF9WpN4jFr5MTB9q7U_75hd4H2xGlGmt988_gI-cTZV846efH4MKK9WA8AkqkjcsrrhlVCdvLdc66FOiFnOT8wxmpdt-_JiZS8UUrLU5IucYshziNOhcJkqZ8KpgkC3ULwFoqPE42OArUe7qeYix_onND6YVcao8VAXUx0dfv7-rLiHYVCix9x12VHn_MTVyJdxzz7AuEDOXYQMn48xHNy9_PH3eqqurn9db36flMNtWClwt65BlTPUQ6NlsL1wgrbtsiBQ89ap5RqQdRtozWKzuleW-WYrDXwmgt5Tr7tZedNv7xoWA5MEMyc_Ajpj4ngzf-Vya_NfdwarbneC3w5CKT4uMFczHLMgCHAhHGTjahV26lO6m5Bqz06pJhzQvcyhjPzZJPZ2WQONi385393e6GffXmdHTfzG1p_Ae-kn94</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2458959379</pqid></control><display><type>article</type><title>Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fink, D L ; Khan, P Y ; Goldman, N ; Cai, J ; Hone, L ; Mooney, C ; El-Shakankery, K H ; Sismey, G ; Whitford, V ; Marks, M ; Thomas, S</creator><creatorcontrib>Fink, D L ; Khan, P Y ; Goldman, N ; Cai, J ; Hone, L ; Mooney, C ; El-Shakankery, K H ; Sismey, G ; Whitford, V ; Marks, M ; Thomas, S</creatorcontrib><description>Summary Background Early coronavirus disease 2019 (COVID-19) diagnosis prior to laboratory testing results is crucial for infection control in hospitals. Models exist predicting COVID-19 diagnosis, but significant concerns exist regarding methodology and generalizability. Aim To generate the first COVID-19 diagnosis risk score for use at the time of hospital admission using the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) checklist. Design A multivariable diagnostic prediction model for COVID-19 using the TRIPOD checklist applied to a large single-centre retrospective observational study of patients with suspected COVID-19. Methods 581 individuals were admitted with suspected COVID-19; the majority had laboratory-confirmed COVID-19 (420/581, 72.2%). Retrospective collection was performed of electronic clinical records and pathology data. Results The final multivariable model demonstrated AUC 0.8535 (95% confidence interval 0.8121–0.8950). The final model used six clinical variables that are routinely available in most low and high-resource settings. Using a cut-off of 2, the derived risk score has a sensitivity of 78.1% and specificity of 86.8%. At COVID-19 prevalence of 10% the model has a negative predictive value (NPV) of 96.5%. Conclusions Our risk score is intended for diagnosis of COVID-19 in individuals admitted to hospital with suspected COVID-19. The score is the first developed for COVID-19 diagnosis using the TRIPOD checklist. It may be effective as a tool to rule out COVID-19 and function at different pandemic phases of variable COVID-19 prevalence. The simple score could be used by any healthcare worker to support hospital infection control prior to laboratory testing results.</description><identifier>ISSN: 1460-2725</identifier><identifier>EISSN: 1460-2393</identifier><identifier>DOI: 10.1093/qjmed/hcaa305</identifier><identifier>PMID: 33165573</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>COVID-19 ; COVID-19 Testing ; Hospitals ; Humans ; Original ; Retrospective Studies ; SARS-CoV-2</subject><ispartof>QJM : An International Journal of Medicine, 2021-12, Vol.114 (10), p.699-705</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-ebff6a5b1e3c6732fb2d2d88e1a1ab08f5558a248677e29f7b7d5f0347a14123</citedby><cites>FETCH-LOGICAL-c420t-ebff6a5b1e3c6732fb2d2d88e1a1ab08f5558a248677e29f7b7d5f0347a14123</cites><orcidid>0000-0002-0873-8355 ; 0000-0003-4210-2411</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33165573$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fink, D L</creatorcontrib><creatorcontrib>Khan, P Y</creatorcontrib><creatorcontrib>Goldman, N</creatorcontrib><creatorcontrib>Cai, J</creatorcontrib><creatorcontrib>Hone, L</creatorcontrib><creatorcontrib>Mooney, C</creatorcontrib><creatorcontrib>El-Shakankery, K H</creatorcontrib><creatorcontrib>Sismey, G</creatorcontrib><creatorcontrib>Whitford, V</creatorcontrib><creatorcontrib>Marks, M</creatorcontrib><creatorcontrib>Thomas, S</creatorcontrib><title>Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital</title><title>QJM : An International Journal of Medicine</title><addtitle>QJM</addtitle><description>Summary Background Early coronavirus disease 2019 (COVID-19) diagnosis prior to laboratory testing results is crucial for infection control in hospitals. Models exist predicting COVID-19 diagnosis, but significant concerns exist regarding methodology and generalizability. Aim To generate the first COVID-19 diagnosis risk score for use at the time of hospital admission using the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) checklist. Design A multivariable diagnostic prediction model for COVID-19 using the TRIPOD checklist applied to a large single-centre retrospective observational study of patients with suspected COVID-19. Methods 581 individuals were admitted with suspected COVID-19; the majority had laboratory-confirmed COVID-19 (420/581, 72.2%). Retrospective collection was performed of electronic clinical records and pathology data. Results The final multivariable model demonstrated AUC 0.8535 (95% confidence interval 0.8121–0.8950). The final model used six clinical variables that are routinely available in most low and high-resource settings. Using a cut-off of 2, the derived risk score has a sensitivity of 78.1% and specificity of 86.8%. At COVID-19 prevalence of 10% the model has a negative predictive value (NPV) of 96.5%. Conclusions Our risk score is intended for diagnosis of COVID-19 in individuals admitted to hospital with suspected COVID-19. The score is the first developed for COVID-19 diagnosis using the TRIPOD checklist. It may be effective as a tool to rule out COVID-19 and function at different pandemic phases of variable COVID-19 prevalence. The simple score could be used by any healthcare worker to support hospital infection control prior to laboratory testing results.</description><subject>COVID-19</subject><subject>COVID-19 Testing</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Original</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><issn>1460-2725</issn><issn>1460-2393</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctP3DAQxi1UVB7tsdfKx15S_Ijj5FKpWtqChMQF9WpN4jFr5MTB9q7U_75hd4H2xGlGmt988_gI-cTZV846efH4MKK9WA8AkqkjcsrrhlVCdvLdc66FOiFnOT8wxmpdt-_JiZS8UUrLU5IucYshziNOhcJkqZ8KpgkC3ULwFoqPE42OArUe7qeYix_onND6YVcao8VAXUx0dfv7-rLiHYVCix9x12VHn_MTVyJdxzz7AuEDOXYQMn48xHNy9_PH3eqqurn9db36flMNtWClwt65BlTPUQ6NlsL1wgrbtsiBQ89ap5RqQdRtozWKzuleW-WYrDXwmgt5Tr7tZedNv7xoWA5MEMyc_Ajpj4ngzf-Vya_NfdwarbneC3w5CKT4uMFczHLMgCHAhHGTjahV26lO6m5Bqz06pJhzQvcyhjPzZJPZ2WQONi385393e6GffXmdHTfzG1p_Ae-kn94</recordid><startdate>20211220</startdate><enddate>20211220</enddate><creator>Fink, D L</creator><creator>Khan, P Y</creator><creator>Goldman, N</creator><creator>Cai, J</creator><creator>Hone, L</creator><creator>Mooney, C</creator><creator>El-Shakankery, K H</creator><creator>Sismey, G</creator><creator>Whitford, V</creator><creator>Marks, M</creator><creator>Thomas, S</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0873-8355</orcidid><orcidid>https://orcid.org/0000-0003-4210-2411</orcidid></search><sort><creationdate>20211220</creationdate><title>Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital</title><author>Fink, D L ; Khan, P Y ; Goldman, N ; Cai, J ; Hone, L ; Mooney, C ; El-Shakankery, K H ; Sismey, G ; Whitford, V ; Marks, M ; Thomas, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-ebff6a5b1e3c6732fb2d2d88e1a1ab08f5558a248677e29f7b7d5f0347a14123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>COVID-19 Testing</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Original</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fink, D L</creatorcontrib><creatorcontrib>Khan, P Y</creatorcontrib><creatorcontrib>Goldman, N</creatorcontrib><creatorcontrib>Cai, J</creatorcontrib><creatorcontrib>Hone, L</creatorcontrib><creatorcontrib>Mooney, C</creatorcontrib><creatorcontrib>El-Shakankery, K H</creatorcontrib><creatorcontrib>Sismey, G</creatorcontrib><creatorcontrib>Whitford, V</creatorcontrib><creatorcontrib>Marks, M</creatorcontrib><creatorcontrib>Thomas, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>QJM : An International Journal of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fink, D L</au><au>Khan, P Y</au><au>Goldman, N</au><au>Cai, J</au><au>Hone, L</au><au>Mooney, C</au><au>El-Shakankery, K H</au><au>Sismey, G</au><au>Whitford, V</au><au>Marks, M</au><au>Thomas, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital</atitle><jtitle>QJM : An International Journal of Medicine</jtitle><addtitle>QJM</addtitle><date>2021-12-20</date><risdate>2021</risdate><volume>114</volume><issue>10</issue><spage>699</spage><epage>705</epage><pages>699-705</pages><issn>1460-2725</issn><eissn>1460-2393</eissn><abstract>Summary Background Early coronavirus disease 2019 (COVID-19) diagnosis prior to laboratory testing results is crucial for infection control in hospitals. Models exist predicting COVID-19 diagnosis, but significant concerns exist regarding methodology and generalizability. Aim To generate the first COVID-19 diagnosis risk score for use at the time of hospital admission using the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) checklist. Design A multivariable diagnostic prediction model for COVID-19 using the TRIPOD checklist applied to a large single-centre retrospective observational study of patients with suspected COVID-19. Methods 581 individuals were admitted with suspected COVID-19; the majority had laboratory-confirmed COVID-19 (420/581, 72.2%). Retrospective collection was performed of electronic clinical records and pathology data. Results The final multivariable model demonstrated AUC 0.8535 (95% confidence interval 0.8121–0.8950). The final model used six clinical variables that are routinely available in most low and high-resource settings. Using a cut-off of 2, the derived risk score has a sensitivity of 78.1% and specificity of 86.8%. At COVID-19 prevalence of 10% the model has a negative predictive value (NPV) of 96.5%. Conclusions Our risk score is intended for diagnosis of COVID-19 in individuals admitted to hospital with suspected COVID-19. The score is the first developed for COVID-19 diagnosis using the TRIPOD checklist. It may be effective as a tool to rule out COVID-19 and function at different pandemic phases of variable COVID-19 prevalence. The simple score could be used by any healthcare worker to support hospital infection control prior to laboratory testing results.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>33165573</pmid><doi>10.1093/qjmed/hcaa305</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-0873-8355</orcidid><orcidid>https://orcid.org/0000-0003-4210-2411</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1460-2725
ispartof QJM : An International Journal of Medicine, 2021-12, Vol.114 (10), p.699-705
issn 1460-2725
1460-2393
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7717412
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects COVID-19
COVID-19 Testing
Hospitals
Humans
Original
Retrospective Studies
SARS-CoV-2
title Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A34%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20internal%20validation%20of%20a%20diagnostic%20prediction%20model%20for%20COVID-19%20at%20time%20of%20admission%20to%20hospital&rft.jtitle=QJM%20:%20An%20International%20Journal%20of%20Medicine&rft.au=Fink,%20D%20L&rft.date=2021-12-20&rft.volume=114&rft.issue=10&rft.spage=699&rft.epage=705&rft.pages=699-705&rft.issn=1460-2725&rft.eissn=1460-2393&rft_id=info:doi/10.1093/qjmed/hcaa305&rft_dat=%3Cproquest_pubme%3E2458959379%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2458959379&rft_id=info:pmid/33165573&rft_oup_id=10.1093/qjmed/hcaa305&rfr_iscdi=true